Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus

Biological Psychiatry

Volumn 49, Issue 6, 2001, Pages 528-539

  Al Amin, Hassen A ^a   Shannon Weickert, Cynthia ^a   Weinberger, Daniel R ^a   Lipska, Barbara K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Animal model; Behavior; Binding; Dizocilpine; Hippocampus; NMDA mRNA; Schizophrenia

Indexed keywords

DIZOCILPINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX LESION; HIPPOCAMPUS; HYPERACTIVITY; MALE; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RAT; SCHIZOPHRENIA;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; HYPERKINESIS; IN SITU HYBRIDIZATION; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RANDOM ALLOCATION; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 0035869617     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00968-9     Document Type: Article

References (111)

1. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development
2. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients
3. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development
4. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus
5. Cortical NMDA levels are increased in adult rats following excitotoxic lesions of the ventral hippocampus
6. Hippocampal formation
7. Social behavior in rats lesioned with ibotenic acid in the hippocampus: Quantitative and qualitative analysis
8. Developmental malformations in cerebral structures of schizophrenic patients
9. MK-801 induced stereotypies in rats are decreased by haloperidol and increased by diazepam
10. Changes in voltage dependence of NMDA currents during development
11. Alterations of neural circuitry within layer II of anterior cingulate cortex in schizophrenia
12. Postpubertal emergence of prefrontal neuronal deficits and altered dopaminergic behaviors in rats with neonatal hippocampal lesions
13. Neonatal hippocampal lesion model of schizophrenia in rats: Sex differences and persistence of effects into maturity
14. The neuropathology of schizophrenic diseases: Historical aspects and present knowledge
15. Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: An electrochemical study in the rat
16. Differential behavioral and neurochemical effects of competitive and noncompetitive NMDA receptor antagonists in rats
17. A role for N-methyl-D-aspartate receptors in the regulation of synaptogenesis and expression of the polysialylated form of the neural cell adhesion molecule in the developing striatum
18. The NMDA antagonist MK801 causes marked locomotor stimulation in monoamine-depleted mice
19. Interfering with glutamatergic neurotransission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems
20. Hippocampal afferents to the rat prefrontal cortex: Synaptic targets and relation to dopamine terminals
21. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia
22. The effect of 1-arylcyclohexylamine (Sernyl) on twelve normal volunteers
23. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens
24. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?
25. Experience-dependent plasticity and the maturation of glutamatergic synapses
26. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus
27. Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat
28. Noncompetitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons
29. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons with other psychostimulants
30. Schizophrenia and the disconnection hypothesis
31. Schizophrenia: A disconnection syndrome?
32. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: A combined retrograde tracing and immunohistochemical study
33. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats
34. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
35. Disruption of latent inhibition in rats with postnatal hippocampal lesions
36. The non-NMDA glutoinate receptor antagonist GYK1 5266 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
37. The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits
38. Regulation of N-methyl-D-aspartate (NMDA) receptor function during the rearrangement of developing neuronal connections
39. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus
40. Effect of phencyclidine in chronic schizophrenics
41. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
42. Recent advances in the phencyclidine model of schizophrenia
43. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin
44. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
45. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: Behavioral and neurochemical evidence
46. Profound neuronal plasticity in response to inactivation of the dopamine transporter
47. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes
48. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum
49. Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons
50. Subanesthetic effects of noncompetitive NMDA receptor antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
51. Ketamine activates psychosis and alters limbic blood flow in schizophrenia
52. Muscarinic antagonists attenuate dizocilpine-induced hypermotility in mice
53. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA
54. Neonatal ventral hippocampal lesions produce an elevation of delta-FosB-like protein(s) in the rodent neocortex
55. Amphetamine-induced c-fos mRNA expression is reduced in rats with neonatal ventral hippocampal lesions
56. Altered levels of extracellular dopamine and 5-HIAA after restraint stress and amphetamine in rats with neonatal ventral hippocampal damage. An in vivo microdialysis study in awake rats
57. Excitotoxic lesions of the rat medial prefrontal cortex: Effects on abnormal behaviors associated with neonatal hippocampal damage
58. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild chronic stress and haloperidol treatment
59. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat
60. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal hippocampal damage: A potential animal model of schizophrenia
61. Regulation of tyrosine hydroxylase and dopamine transporter mRNA by antipsychotic drugs in a rat model of schizophrenia
62. Neonatal excitotoxic hippocampal damage in rats causes postpubertal changes in prepulse inhibition of startle and its disruption by apomorphine
63. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat
64. Gonadectomy does not prevent novelty- or drug-induced hyperresponsiveness in rats with neonatal excitototxic hippocampal damage
65. Subchronic treatment with haloperidol or clozapine in rats with neonatal excitotoxic hippocampal damage
66. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats
67. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats
68. The behavioural effects of MK-801 in rats: Involvement of dopaminergic, serotonergic and noradrenergic systems
69. Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: Role of neuronal activity
70. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens
71. 14C-plastic standards for quantitative autoradiography using LKB Ultrafilm or Amersham Hyperfilm
72. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
73. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
74. Neonatal damage of the rat ventral hippocampus impairs acquisition of a working memory task
75. Differential stimulation of [3H]MK-801 binding to subpopulations of NMDA receptors
76. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
77. Molecular cloning and characterization of the rat NMDA receptor
78. Effects of neonatal hippocampal lesions on prefrontal cortical pyramidal cell responses to VTA stimulation
79. Ketamine: An update on the first twenty-five years of clinical experience
80. Regional distribution and properties of [3H]MK-801 binding sites determined by quantitative autoradiography in rat brain
81. Phencyclidine-induced stereotyped behavior and social isolation in rats: A possible animal model of schizophrenia
82. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood
83. Development of glutamate binding sites in the visual structures of the rat brain. Effect of visual pattern deprivation
84. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other
85. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
86. Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex
87. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat
88. Microdialysis studies of excitatory amino acid transmitters in a rat model of schizophrenia
89. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclolhepten-5,10-imine ([3H]MK-801) in rat brain: Regional effects of polyamines
90. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing
91. Interactions between catecholamines and serotonin: Relevance to the pharmacology of schizophrenia
92. Neural networks and synaptic transmission in immature hippocampus
93. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of frontal cortex or hippocampus in adult rats
94. Cortical regulation of subcortical dopamine release: Mediation via the ventral tegmental area
95. Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex
96. Transient increased density of NMDA binding sites in developing rat hippocampus
97. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine
98. Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study
99. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions
100. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: Behavioral and in vivo microdialysis studies
101. Developmental changes in distribution of NMDA receptor channel subunit mRNAs
102. MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors
103. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins
104. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: In search of common ground
105. Ketamine - Pharmacology and therapeutic uses
106. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro
107. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801
108. The role of excitatory amino acids in behavioural sensitisation to psychomotor stimulants
109. Behavioural sensitization to MK-801 (dizocilpine): Neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system
110. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex